Alzheimer’s spotlight
July 8, 2011
PHARMACISTS will have the
opportunity to learn about the
latest clinical strategies for the
treatment of Alzheimer’s disease at
the Pharmaceutical Society of
Australia’s upcoming PAC11.
The presentation will be delivered
by noted expert, Professor Jürgen
Götz, Chair of Molecular Biology
and Director of the Alzheimer’s and
Parkinson’s Laboratory at the Brain
and Mind Research Institute of the
University of Sydney.
His presentation, Dementia –
Understanding the underlying
mechanisms and translating into
practice, will cover strategies
including vaccination and the
modulation of the formation,
aggregation and clearance of
proteins such as Abeta, and tau.
“To test treatment strategies, we
established transgenic mouse
models that reproduce key features
of the human pathology,” said Götz.
“These treatment strategies will
be discussed in the context of
ongoing strategies for AD in
pharmaceutical settings,” he added.
For info see www.pac11.com.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 08 Jul 11To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Jul 11
